al. Body measurements, estrogen availability and the risk of human breast cancer: a casecontrol study. Int J Cancer 1992;51:14-9. (4) Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW. Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst 1996;88:32-7. (5) Mettlin CJ, Piver MS. A case-control study of milk-drinking and ovarian cancer risk. Am J Epidemiol 1990;132:871-6. (6) Engle A, Muscat JE, Harris RE. Nutritional risk factors and ovarian cancer. Nutr Cancer 1991;15:239-47. (7) Risch HA, Jain M, Marrett LD, Howe GR. Dietary fat intake and risk of epithelial ovarian cancer. J Natl Cancer Inst 1994;86:140915. (8) Slattery ML, Schuman KL, West DW, French TK, Robison LM. Nutrient intake and ovarian cancer. Am J Epidemiol 1989;130:497502. (9) Polychronopoulou A, Tzonou A, Hsieh CC, Kaprinis G, Rebelakos A, Toupadaki N, et al. Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int J Cancer 1993;55:402-7. (10) Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish recordlinkage study. Eur J Cancer 1994;30A:344-50. (11) Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 1986;23(Pt 5):514-20. (12) Salkeld RM, Keller HE. Roche guidelines for vitamin status in adults. Basel, Switzerland: Vitamins and Fine Chemicals Division, Hoffmann-La Roche, 1988. (13) Gerber M, Astre C, Segala C, Saintot M, Scali J, Simony-Lafontaine J, et al. Oxidantantioxidant status alterations in cancer patients: relationship to tumor progression. J Nutr 1996;126(4 Suppl):1201S-7S. (14) Saintot M, Astre C, Pujol H, Gerber M. Tumor progression and oxidant-antioxidant status. Carcinogenesis 1996;7:1267-71. (15) Das NP, Ma CW, Salmon YM. The relationship of vitamin A, cholesterol, and triglycerides to the incidence of ovarian cancer. Biochem Med Metab Biol 1987;37:213-9.